Patents Assigned to ReJoy
  • Treatment of sexual dysfunction
    Patent number: 10357452
    Abstract: Compositions and methods for treating sexual dysfunction and enhancing sexual satisfaction using topical application of a therapeutic agent such as an alpha-1 adrenergic receptor agonist to the nipple-areola complex are disclosed.
    Type: Grant
    Filed: June 19, 2018
    Date of Patent: July 23, 2019
    Assignee: Rejoy
    Inventors: Ofer A. Goren, John McCoy
  • TREATMENT OF SEXUAL DYSFUNCTION
    Publication number: 20180296471
    Abstract: Compositions and methods for treating sexual dysfunction and enhancing sexual satisfaction using topical application of a therapeutic agent such as an alpha-1 adrenergic receptor agonist to the nipple-areola complex are disclosed.
    Type: Application
    Filed: June 19, 2018
    Publication date: October 18, 2018
    Applicant: ReJoy
    Inventors: Ofer A. Goren, John McCoy
  • Treatment of sexual dysfunction
    Patent number: 10064816
    Abstract: Compositions and methods for treating sexual dysfunction and enhancing sexual satisfaction using topical application of a therapeutic agent such as an alpha-1 adrenergic receptor agonist to the nipple-areola complex are disclosed.
    Type: Grant
    Filed: June 10, 2016
    Date of Patent: September 4, 2018
    Assignee: Rejoy
    Inventors: Ofer A. Goren, John McCoy
  • TREATMENT OF SEXUAL DYSFUNCTION
    Publication number: 20180078499
    Abstract: Compositions and methods for treating sexual dysfunction and enhancing sexual satisfaction using topical application of a therapeutic agent such as an alpha-1 adrenergic receptor agonist to the nipple-areola complex are disclosed.
    Type: Application
    Filed: June 10, 2016
    Publication date: March 22, 2018
    Applicant: Rejoy
    Inventors: Ofer A. Goren, John McCoy
  • TREATMENT OF SEXUAL DYSFUNCTION AND FOR IMPROVED SEXUAL QUALITY OF LIFE
    Publication number: 20170165253
    Abstract: Compositions and methods for treating sexual dysfunction and enhancing sexual satisfaction using topical application of alpha-1 adrenergic receptor agonists, muscarinic acetylcholine receptor agonists, nicotinic acetylcholine receptor agonists, and cholinesterase inhibitors are disclosed.
    Type: Application
    Filed: November 17, 2016
    Publication date: June 15, 2017
    Applicant: ReJoy
    Inventors: Ofer A. GOREN, John McCoy